ArticleACS medicinal chemistry letters2015

Fragment-Based Drug Design of Novel Pyranopyridones as Cell Active and Orally Bioavailable Tankyrase Inhibitors.

Javier de Vicente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.